Hainan Guoxie Technology Group, a subsidiary of Meihua International Medical Technologies (MHUA), has started the construction of a medical industrial park project in the Hainan Free Trade Port Boao Hope City (Hope City) in China.
Designed to be built as a high-end comprehensive medical industrial park, the new project is being constructed on the land that was acquired earlier around Hope City.
MHUA has successfully made the final payment to acquire the land in Hope City, securing a land use right for 50 years for a total area of 47,971m².
When completed, the medical industrial park will cover the manufacturing and global trade of essential medical devices.
The primary focus of the new facility will be on researching, developing, manufacturing and testing surgical robots.
The company is currently in the process of finalising the details for a collaboration with an Israeli company to develop and produce surgical robot technology.
These robots will primarily be used for the remote training of doctors and performing complex surgeries.
The new park will also include a secondary hospital for providing a comprehensive range of services, including stem cell extraction and storage, clinical trials and advanced therapeutic solutions. These services will be integrated with robotic assistance.
The hospital is expected to house over 300 individual beds, with a primary focus on serving discerning clientele and the elderly wellness communities.
According to the plan, the industrial park will have a research and development centre for medical products.
An assembly production workshop for imported goods and an export sales company will also be part of the medical park.
In addition, it will offer integrated solutions for hospital-based elderly care services.
MHUA chairman Yongjun Liu said: “The entire venture aims to provide cutting-edge and innovative solutions for medical services in Qionghai and the surrounding regions of Hainan.
“Leveraging the unique policy advantages of Hope City and the exceptional wellness environment it offers, we are committed to continuing to introduce exceptional exported products and patents in research and technology.”
